While we currently have highly effective vaccines that protect against the virus that causes COVID-19, medical research continues to identify effective treatments.
Treatments approved and authorized for emergency use by the Food and Drug Administration (FDA) are listed below.
Talk to your healthcare provider about which treatment might be right for you.
Available COVID-19 Treatments
There are several treatments being used for COVID-19.
- Evusheld (mAb)
- Bebtelovimab (mAb)
Visit Know Your Treatment Options For COVID-19 for additional information regarding treatment options. Please contact your healthcare provider to determine which treatment might be right for you.
Emergency Use Authorization (EUA) Treatments
Monoclonal antibodies (mAbs)
Monoclonal antibodies (mAbs) treatments are issued by the FDA for emergency use under certain conditions. Currently, mAbs are used for treatment of people who have COVID-19 and:
- To block the virus from entering your cells.
- To reduce the severity of disease and incidence of hospitalization.
- Preventive treatment for high-risk people who may be routinely exposed to the virus that causes COVID-19.
- Preventive treatment for people who are immunocompromised or cannot receive the COVID-19 vaccine for medical reasons.
Different antiviral treatments work in different ways.
Remdesivir (Veklury) is an FDA approved injectable antiviral treatment for adults and pediatrics patients. It is used as a treatment option to reduce the risk of hospitalization in high-risk patients.
- The FDA recently expanded to certain non-hospitalized (outpatient) adults and pediatric patients
- OHA currently does not have a role in distributing this treatment
Molnupiravir is an oral antiviral medicine for treatment of mild-to-moderate COVID-19 disease and who:
- Have tested positive for COVID-19
- Are 18 years or older
NOTE: This medicine is not recommended for children or people who are pregnant or breastfeeding
Paxlovid is an oral antiviral medicine for treatment of mild-to-moderate COVID-19 disease and who:
- Have tested positive for COVID-19
- Are 12 years and older
NOTE: This medicine is not recommended for people with severe liver and kidney disease, an allergy to one of the medicine’s ingredients, or with poorly controlled HIV infection.
Test to Treat (T2T) and Federal Retail Pharmacy Therapeutics Program (FRPTP)
The Test to Treat (T2T) program connects eligible people who are at high risk of severe COVID-19 to treatments. These locations will provide access for people to get tested, receive a prescription from a health care provider, and fill that prescription, all at one place. This program is for those without a healthcare provider or for those who cannot get in to see their healthcare provider for COVID-19 symptoms, but it is not limited to just these people, anybody can seek treatment at a T2T location.
The Federal Retail Pharmacy Therapeutics Program (FRPTP) is a program that allows people to get their medications dispensed at a participating pharmacy. This will allow patients who have already been seen by a healthcare provider and have a prescription for an oral antiviral, have their medicines given to them by these pharmacies. Please use the locator below for more information. OHA is working to make these therapeutics more available to rural communities by searching for additional pharmacies to partner with.
The federal government has released the Test to Treat Locator to make it easier to find Test to Treat (T2T) locations.This locator allows you to:
- Enter the correct address, city or zip code
- Select the distance from the location entered (in miles)
- Search locations that include testing, provider visit, and getting the prescription filled (T2T)
- Search locations to fill a prescription (Federal Retail Pharmacy Therapeutic Program sites included)
IMPORTANT: Please check the locator often as sites continue to be added.
Oregon Health Authority is aware of the loss of Health Resources and Services Administration (HRSA) funding and is working to find solutions. Without the HRSA funding, those without insurance may have costs associated with COVID-19 therapeutic access such as provider assessment and pharmacy dispensing fees. At this time, Oregon Health Authority is working with our government partners to find solutions and will continue to provide updates as we know more.
COVID-19 Therapeutics Locator
The federal government released the COVID-19 Therapeutics Locator that shows public locations receiving the available COVID-19 therapeutics. The locator shows places near you that have these medicines and can help guide you when having conversations with your healthcare provider.
Please consider the important notes below when using this locator:
- These medicines are intended for those who are at high risk for severe illness from COVID-19
- You must be evaluated by a healthcare provider to make sure you are eligible for these medicines
- Sites drop off and are added to the list frequently, so there is not a guarantee of availability
- The locator includes specialty sites that may not be able to serve everyone
- Please allow your healthcare provider to contact sites to verify availability
- This locator is not the same as the Test to Treat (T2T) locator
If you have any questions about this site, please contact 1-800-232-0233 (TTY 888-720-7489). For additional questions, please contact us at OHA.firstname.lastname@example.org.
- Community Webinar – 4.30.22 recording
- Community Webinar – 4.30.22 slide deck
- COVID-19 treatments Paxlovid and Molnupiravir available to eligible patients
COVID-19 Therapeutics Newsletters
Videos in American Sign Language (ASL)
- What is Paxlovid?
- Who is Paxlovid for?
- Who should not take Paxlovid?
- How is Paxlovid administered?
- Is Paxlovid available now?
Monoclonal antibodies (mAbs)
- What are monoclonal antibodies?
- Why get mAbs therapy?
- Who is eligible for mAbs therapy?
- What can you expect if you get the mAbs treatment?
- What can you expect if you get the infusion treatment?
- What can you expect if you get mAbs treatment as injections?
- What are some of the side effects?
- Are there any rare allergic reactions?
- What are the different types of treatment?
- What can you expect after treatment?
- Where can you report serious side effects?
Long-Acting Monoclonal antibodies (mAbs)
- What are long-acting monoclonal antibodies?
- Why use long-acting mAbs?
- How are long-acting mAbs given?
- Are long-acting mAbs available now?
- What are some long-acting mAbs?
Accessibility: For individuals with disabilities or individuals who speak a language other than English, OHA can provide information in alternate formats such as translations, large print, or braille. Contact the Health Information Center at 1-971-673-2411, 711 TTY or COVID19.LanguageAccess@dhsoha.state.or.us
Printing requests: You can download materials on this page. OHA does not offer paper versions. Please feel free to print whatever you need.
Language access: OHA is working to provide original content in languages other than English. Many of the materials in our community resources section are available in multiple languages. OHA is also providing the Google™ Translate option to assist you in reading the OHA website in languages other than English. Google™ Translate cannot translate all types of documents and may not provide an exact translation. Anyone relying on information obtained from Google™ Translate does so at their own risk. OHA does not make any promises, assurances, or guarantees as to the accuracy of the translations provided.
General vaccine questions: ORCOVID@211info.org